MedPath

To identify the NIFTP(Non invasive follicular thyroid neoplasm with papillary like nuclear features) by using certain IHC markers on follicular adenomas. Both are encapsulated lesions.

Not Applicable
Conditions
Health Condition 1: C73- Malignant neoplasm of thyroid gland
Registration Number
CTRI/2021/12/038833
Lead Sponsor
Maulana Azad Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All cases of follicular adenomas.

2.Capsule completely processed.

Exclusion Criteria

1.Other histology, diffuse infiltrative lesions.

2.Multiple foci of tumor and ruptured capsule.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expression of CK19,CD 56, CD 57 in follicular adenomas.Timepoint: 4-8 weeks.
Secondary Outcome Measures
NameTimeMethod
Based on the expression of these markers differentiating follicular adenomas from NIFTP.Timepoint: one year
© Copyright 2025. All Rights Reserved by MedPath